Therapeutic options in juvenile idiopathic arthritis Surgical and conservative orthopedic rheumatological treatment

被引:1
|
作者
Haas, J. -P. [1 ]
Arbogast, M. [2 ]
机构
[1] Zentrum Schmerztherapie Junger Menschen, Deutsch Zentrum Kinder & Jugendrheumatol, Gehfeldstr 24, D-82467 Garmisch Partenkirchen, Germany
[2] Zentrum Rheumatol Orthopadie & Schmerztherapie Kl, Abt Rheumaorthopadie & Handchirurg, Oberammergau, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2021年 / 80卷 / 05期
关键词
Multidisciplinary treatment; Inflammatory activity; Remission; Pediatric rheumatology; Functional restoration;
D O I
10.1007/s00393-021-00996-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The treatment of juvenile idiopathic arthritis (JIA) has made substantial progress within the last 25 years. Modern medicinal treatment enables inflammatory activity of the disease to be controlled in most of the cases. Mutilating courses of disease, which were formerly the rule have now become the exception. Today remission of disease is the aim of pediatric rheumatological treatment. Apart from effective control of inflammation this includes complete restoration of functional abilities of affected joints and the surrounding structures also affected. To achieve this goal a holistic and foresighted view of each patient's course is required. Therefore, even in an apparently uncomplicated course of disease in some cases of JIA it is advisable to plan an early interdisciplinary consultation including the pediatric rheumatologist and the orthopedic surgeon, in order to discuss an early surgical intervention, which can then be carried out in a timely manner, if necessary. This article provides an overview of the orthopedic rheumatological indications and options.
引用
收藏
页码:467 / 480
页数:14
相关论文
共 50 条
  • [41] Update on the Treatment of Juvenile Idiopathic Arthritis
    Julia G. Harris
    Elizabeth A. Kessler
    James W. Verbsky
    Current Allergy and Asthma Reports, 2013, 13 : 337 - 346
  • [42] Glucocorticoid treatment in juvenile idiopathic arthritis
    Batu, Ezgi Deniz
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (01) : 13 - 27
  • [43] Medical treatment of juvenile idiopathic arthritis
    Hashkes, PJ
    Laxer, RM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (13): : 1671 - 1684
  • [44] Glucocorticoid treatment in juvenile idiopathic arthritis
    Ezgi Deniz Batu
    Rheumatology International, 2019, 39 : 13 - 27
  • [45] Methotrexate in the treatment of juvenile idiopathic arthritis
    Seeliger, S
    Niehues, T
    Harms, E
    Frosch, M
    Roth, J
    MONATSSCHRIFT KINDERHEILKUNDE, 2002, 150 (04) : 452 - 459
  • [46] Update on the Treatment of Juvenile Idiopathic Arthritis
    Harris, Julia G.
    Kessler, Elizabeth A.
    Verbsky, James W.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2013, 13 (04) : 337 - 346
  • [47] Modern treatment of juvenile idiopathic arthritis
    Horneff, G.
    MONATSSCHRIFT KINDERHEILKUNDE, 2014, 162 (08) : 693 - 700
  • [48] Tocilizumab for the Treatment of Juvenile Idiopathic Arthritis
    Decelle, Kendra
    Horton, Evan R.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (06) : 822 - 829
  • [49] Infliximab in the treatment of juvenile idiopathic arthritis
    Tzaribachev, N.
    Holzer, U.
    Hansmann, S.
    Schedel, J.
    Kuemmerle-Deschner, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 59 - 59
  • [50] Juvenile Idiopathic Arthritis: Diagnosis and Treatment
    Giancane G.
    Consolaro A.
    Lanni S.
    Davì S.
    Schiappapietra B.
    Ravelli A.
    Rheumatology and Therapy, 2016, 3 (2) : 187 - 207